#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastric cancer Bulbospinal muscular atrophy congenital Colon cancer Nodal marginal zone B-cell lymphoma Trigeminal neuralgia Anti-glomerular basement membrane disease Diffuse large B-cell lymphoma Oesophageal squamous cell carcinoma stage II Hyperoxaluria Chronic inflammatory demyelinating polyradiculoneuropathy Neuroendocrine tumour of the lung Deafness Synovial sarcoma Precursor T-lymphoblastic lymphoma/leukaemia recurrent Isodicentric chromosome 15 syndrome More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus – Diagnostics Chondrosarcoma metastatic – Diagnostics Fabry’s disease – Diagnostics Langerhans’ cell histiocytosis – Basic Information Propionic acidaemia – Trials in Disease Chordoma – Diagnostics Haemophilia A with anti factor VIII Osteosarcoma – Basic Information Choroid melanoma – Diagnostics Haemophilia A without inhibitors – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gadoteridol Db-Oto-3 Human Coagulation Factor X Hydrocortisone Acetate Hydralazine Hydrochloride DAPIGLUTIDE PEGVISOMANT Savolitinib Nemtabrutinib Isoflurane Nvdx3 Pf-06835375 Desonide Rct2100 Osimertinib Ibuprofen Arginine Varenicline RO7268489 Amb-05X Blu-222 More therapies…

    Learn about Your Condition

    Injury Anal fissure Urethral valves Exfoliation glaucoma Infantile spasms Neurotrophic keratopathy Takayasu's arteritis Primary adrenal insufficiency Epileptic encephalopathy Paresis Lennox-Gastaut syndrome Hepatorenal syndrome Ulcerative keratitis Nervous system disorder Thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hippokration Hospital

Hippokration Hospital

Vassilissas Sofias Avenue 114, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS
    • GSKVX000000025896
    • MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED)
    Belgium Bulgaria Denmark Estonia Greece Lithuania +2

  • Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

    Recruiting

    3 1
    Bulgaria Czechia Denmark France Germany Greece +7

  • Study of tulisokibart compared to placebo in adults with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Tulisokibart
    Austria Belgium Croatia Czechia Denmark Finland +15

  • Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

    Recruiting

    3 1
    Investigated Drugs:
    • IBUZATRELVIR
    • Remdesivir
    Belgium Denmark France Germany Greece The Netherlands +3

  • Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Maridebart Cafraglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +12

  • Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

    Recruiting

    3 1
    Investigated Drugs:
    • Finerenone
    Croatia Czechia Greece Hungary Italy Poland +1

  • Study to Find Treatments for Chronic Kidney Disease Using Finerenone in Patients with Standard Care

    Recruiting

    3 1 1
    Investigated Drugs:
    • Finerenone
    Greece Spain

  • Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

    Recruiting

    3 1
    Investigated Drugs:
    • OMECAMTIV MECARBIL
    France Germany Greece Italy Poland Spain

  • Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Czechia Denmark France Germany Greece +8

  • Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9
Previous Page
1 2 3 4 5 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!